Published July 24, 2026
A Genuinely Clever Argument Is Circulating. It Deserves a Careful Look — and a Careful Correction.
For eight months, everyone covering the November 12 hemp deadline — this publication included — has used the same word: ban. On that date, the federal definition of hemp narrows, and by industry estimates roughly 95% of hemp cannabinoid products become federally unlawful.
This week a different framing started circulating: what if it isn’t a ban at all, but a reunification?
The argument, laid out in an op-ed by law student Anthony Deininger published by The Marijuana Herald, goes like this. If the ongoing rescheduling process finishes moving marijuana to Schedule III before November 12, then products losing their hemp status wouldn’t be banned — they’d simply fall back under the marijuana umbrella and land in Schedule III alongside it. Only synthetic cannabinoids would remain in Schedule I. Hemp and marijuana, separated by the 2018 Farm Bill, reunited under one roof.
It’s a sharp observation, and the statutory mechanics underneath it are real. It’s also, on close examination, unlikely to deliver the relief a hopeful hemp operator might read into it. Both of those things are worth understanding, because the gap between them is where people make expensive mistakes.
First, Why the Mechanics Actually Work
The theory rests on a feature of federal drug law that’s underappreciated even by people who follow this closely: hemp isn’t a separately scheduled substance. It’s a carve-out.
Under the Controlled Substances Act, “marihuana” is defined broadly enough to capture the cannabis plant and its derivatives. The 2018 Farm Bill didn’t create a new legal category so much as cut a hole in that definition — anything meeting the hemp standard (then, 0.3% delta-9 THC by dry weight) is excluded from the definition of marijuana, and therefore isn’t a controlled substance at all. Major law firm analyses of April’s rescheduling order confirm the structure plainly: hemp “remains excluded from the definition of marijuana under the CSA.”
Now follow the logic to November 12. The hole in the definition gets much smaller. Products that no longer meet the narrowed hemp standard don’t vanish into a special prohibited category — they fall back into the definition of marijuana. And once something is marijuana, its schedule is whatever marijuana’s schedule is.
That’s the whole insight, and it’s correct: the fate of those products is determined by marijuana’s scheduling status on the day they lose hemp protection. If marijuana is still Schedule I that day, they become Schedule I — the “ban.” If marijuana has been moved to Schedule III first, they become Schedule III.
Even mainstream commentary has been describing the November change in these terms without quite drawing out the implication — as one recent op-ed put it, the definition change is “folding hemp-derived products back under the marijuana umbrella.” The reunification framing simply notices that the umbrella might be a different color by then.
Problem One: The Timing Premise Is Doing Enormous Work
Every bit of the theory’s relief depends on full rescheduling being complete before November 12. That’s a much heavier lift than it sounds.
As we’ve covered, the DEA hearing that closed July 15 was an evidence-gathering proceeding, not a verdict. What follows is post-hearing briefs, then a recommended decision from the administrative law judge — who faces no statutory deadline — then review by the DEA Administrator, then a final rule, then likely OMB review, then an effective date. Historically, the ALJ stage alone has taken years; in the 1980s rescheduling proceeding it ran two years before the Administrator rejected the recommendation outright.
There’s a fresher signal too. In confirmation testimony this month, Acting Attorney General Todd Blanche declined to commit to rescheduling beyond medical marijuana. The official sitting atop this process just pointedly refused to promise the very outcome the reunification theory requires — and requires within sixteen weeks.
Could it happen? The administration is under an executive order to move “expeditiously,” and the hearing ran on a compressed schedule for exactly that reason. But betting a business on full rescheduling landing before November 12 is betting on the fastest plausible version of a process with no deadlines and a decision-maker who won’t commit.
Problem Two: Schedule III Is Not Legal
This is the correction that matters most, and it’s where an optimistic reading of the theory could genuinely hurt someone.
Schedule III is not a legal-to-sell category. It’s a controlled substance category. Schedule III substances are lawfully handled only by DEA-registered parties, generally require FDA approval to be marketed as drugs, and are dispensed by prescription. Testosterone and codeine-containing products sit in Schedule III — you cannot sell them at a gas station because they’re “only” Schedule III.
So walk through what reunification would actually mean for a hemp beverage company on November 13. Its product is no longer hemp. It’s now marijuana. Under the friendly version of the theory, that marijuana is Schedule III rather than Schedule I. The company is still not a DEA registrant, still has no FDA approval, still isn’t a state-licensed cannabis operator, and is still selling an unapproved controlled substance through convenience stores. It has traded one form of federal illegality for another.
Schedule III meaningfully changes things for licensed operators — most notably by lifting the 280E tax burden. It does essentially nothing to make an unlicensed hemp retail channel lawful. “Reunited with marijuana” and “saved” are very different sentences.
Problem Three: The Lawyers Who Do This for a Living Disagree
It’s worth weighing the theory against how practicing cannabis attorneys are advising clients, because the contrast is stark.
Vicente LLP, one of the more prominent firms in the space, addressed the interaction directly and concluded that while rescheduling is a genuine win for the industry, “rescheduling does not resolve the hemp ban.” Firms across the sector have spent months telling hemp clients to plan for reformulation, inventory decisions, and compliance changes ahead of November — not to wait for a scheduling change to render the problem moot.
That’s not proof the theory is wrong on the mechanics. It’s evidence that the people with malpractice exposure aren’t treating it as a viable plan.
So What Is the Theory Actually Good For?
Dismissing it entirely would be a mistake, because it surfaces something genuinely clarifying: the November hemp deadline and the rescheduling process are not two separate stories. They’re one interlocking system, and almost all coverage — again, ours included — has treated them as parallel tracks.
That insight has real analytical value. It explains why the administration has been pressing Congress to amend the hemp definition even while pushing rescheduling forward: officials appear to understand these policies collide. It explains why the pending legislative fixes matter more than the scheduling question for hemp specifically. And it gives operators a genuinely useful lens — the outcome in November depends not just on whether Congress acts, but on the sequencing of two federal processes running on different clocks.
For a hemp business making decisions right now, though, the practical guidance doesn’t change. Reformulation planning, inventory strategy, and compliance work should proceed on the assumption that November 12 arrives as written. If full rescheduling lands first and softens the landing, that’s an upside surprise. It is not a plan.
The most useful version of this theory isn’t “the ban isn’t real.” It’s “the ban’s severity depends on a race between two federal processes — and right now, one of them has no deadline and the other has a hard one.”
Part of our ongoing coverage of the November hemp deadline — see our breakdown of the ban’s per-container rule and our explainer on what actually happens after the DEA hearing. Follow the rest at our Cannabis News hub.
Sources:
The Marijuana Herald op-ed by Anthony Deininger — the theory itself, attributed as a law student’s argument: https://themarijuanaherald.com/2026/07/the-hemp-ban-that-is-not-a-ban-but-a-reunification/
Foley & Lardner (hemp’s exclusion from the CSA marijuana definition — the mechanical foundation): https://www.foley.com/insights/publications/2026/04/dea-issues-long-awaited-final-order-rescheduling-certain-marijuana-products-to-schedule-iii-what-it-means-what-it-doesnt-and-what-comes-next/
Vicente LLP (the direct counterweight: “rescheduling does not resolve the hemp ban”): https://vicentellp.com/insights/2026-federal-hemp-ban-what-it-means-for-the-future-of-consumable-hemp-products/
Vicente LLP (Schedule III status doesn’t legalize state-authorized operations): https://vicentellp.com/insights/cannabis-rescheduling-explained/
Marijuana Moment (Blanche declining to commit to broader rescheduling): https://www.marijuanamoment.net/senator-presses-trump-ag-on-cannabis-rescheduling-newsletter-july-22-2026/